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Abstract
The tolerance of bacterial populations to biocidal or antibiotic treatment has been well documented
in both biofilm and planktonic settings. However, there is still very little known about the mechanisms
that produce this tolerance. Evidence that small, non-mutant subpopulations of bacteria are not affected
by antibiotic challenge has been accumulating and provides an attractive explanation for the failure of
typical dosing protocols. Although a dosing challenge can kill all the susceptible bacteria, the remaining
persister cells can serve as a source of population regrowth. We give a robust condition for the failure of
a periodic dosing protocol for a general chemostat model, which supports the mathematical conclusions
and simulations of an earlier, more specialized batch model. Our condition implies that the treatment
protocol fails globally, in the sense that a mixed bacterial population will ultimately persist above a
level that is independent of the initial composition of the population. We also give a sufficient condition
for treatment success, at least for initial population compositions near the steady state of interest,
corresponding to bacterial washout. Finally, we investigate how the speed at which the bacteria are
wiped out depends on the duration of administration of the antibiotic. We find that this dependence is
not necessarily monotone, implying that optimal dosing does not necessarily correspond to continuous
administration of the antibiotic. Thus, genuine periodic protocols can be more advantageous in treating
a wide variety of bacterial infections.
Keywords: persister, biofilm, model, chemostat, tolerance
1 Introduction
The failure of antibiotic treatments to eliminate bacterial infections has become both more evident and
better understood in the past several decades. Although there is evidence that the over use of antibiotics
has amplified the number of chromosomal-resistant bacteria [18], it is becoming increasingly clear that there
are other mechanisms that protect populations of bacteria. Many of these mechanisms depend on whether
the bacteria exist in a biofilm or not [8, 10, 13, 9]. In particular, the notion that small sub-populations
of bacteria may display innate tolerance to various biocides has been proposed as a possible reason for the
failure of treatment for bacterial infections [16, 2, 14, 5]. Bacteria within a biofilm are enmeshed in a physical
gel that provides a secondary boundary that may allow small numbers of bacteria to evade the antibiotic;
therefore, the failure to eliminate the entire population can allow the population to regrow.
It should be noted that populations of planktonic bacteria also contain these highly tolerant or persister
cells [9, 21]. Thus understanding the process of persister formation and the response of the population to
biocidal application is fundamental to developing dosing protocols and treatments in both batch culture and
biofilm populations.
As in many areas of biology, mathematical modeling has been used as a counterpart to experimental
observations. Because there are several hypotheses regarding the mechanism of persister formation, math-
ematical modeling can be used to provide insight into the success of failure of treatment protocols as well
as the consistency of various hypotheses. Currently, there are at least two distinct hypotheses concerning
persister formation-one of which is senescence. In this case, persister cells are assumed to be those that have
undergone many division cycles. It is known that asymmetric division leads to degradation of parts of the
cellular machinery that may be the underlying cause of persistence [19]. Mathematical analysis of a model
of senescence has been described in both chemostat and biofilm settings [14, 1].
A different hypothesis argues that persisters are a phenotype that is expressed at a rate that depends
on the external environment. Although the biological details are not well understood, it is thought that
this might be due to toxin/antitoxin interaction or some other stress response [16, 13, 2, 21, 17]. This has
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been investigated mathematically as well [2, 5, 6, 12]. In [5], a very simple model of persister formation was
developed and optimal dosing protocols, that entail alternating application and resting, were described. In
[6], toxin/antitoxin interaction was explicitly included and the resulting model was analyzed in a chemostat.
In both of these investigations only one particular form of the kinetics was analyzed. One of the goals of
the current investigation is to extend these results to a more general form for kinetics. This is an important
process, because it has been shown that not only is there a successful dosing protocol, there is an optimal
protocol. Without knowing how robust the model is, there is no way to determine how robust the conclusions
are. Here we take a model of the form proposed in [5] and give a condition that yields successful dosing
protocols, at least for some initial makeups of the population.
The manuscript is organized as follows: We begin by describing the model for the dynamics of the bacterial
population in response to antibiotic challenge. We then develop the theory by analyzing two extreme cases
(no dosing and constant dosing) and the intermediate case. This leads to a local sufficient condition for
treatment success. Next we give a condition for global treatment failure, supported by numerical simulations
of the model. We also show that the speed of eradication does not necessarily depend monotonically on the
duration of the administration of the antibiotic.
2 Model
Consider the following chemostat model:
B˙s = [(1− kd(t)− kl(t)) f(S)−D]Bs + kg(t)Bp (1)
B˙p = kl(t)f(S)Bs − [kg(t) +D]Bp (2)
S˙ = D(S0 − S)− f(S)Bs
Y
(3)
where Bs is the concentration of the cells which are susceptible to antibiotics, Bp is the concentration of
the persister cells which are not affected by the antibiotic and S is the concentration of the nutrient. This
model deviates from the one in [5] because it is a chemostat model, which is reflected in the additional loss
terms at rate D (called the dilution rate or washout rate), and the inflow (at the same rate D) of nutrient
with an input concentration S0. The per capita growth rate of the susceptible cells is denoted by f(S), for
which we assume the following throughout the rest of the paper:
f : R+ → R+ is smooth and increasing and f(0) = 0.
The persister cells do not consume nutrient, hence the lack of a corresponding growth term in the Bp-
equation. The conversion of nutrient into new biomass occurs with a yield of Y ∈ (0, 1).
The remaining functions kd(t), kl(t) and kg(t) are non-negative, time-varying functions which describe
the effect of antibiotics on the population. First, kd(t)f(S) is the killing rate of the susceptible population.
Note in particular that the killing rate is proportional to the growth rate of the cells. It is positive when
both antibiotic and nutrient are present, but zero when either one is missing. Secondly, kl(t) is the rate at
which susceptible cells switch to persister cells. It is also positive when antibiotic is present, but zero when
this is not the case. Finally, kg(t) is the rate at which persister cells revert to the susceptible state when
antibiotic is absent (and zero when antibiotic is present).
Since antibiotics are administered to the reactor vessel in a controlled (lab) environment, we will make
the simplifying assumption that the functions kd(t), kl(t) and kg(t) are τ -periodic (for some given τ > 0),
and of the bang-bang type with simultaneous switching instances: For some p ∈ [0, 1], and for positive
parameters kd, kl and kg, there holds that
kd(t) =
{
kd for t ∈ [0, pτ)
0 for t ∈ [pτ, τ) , kl(t) =
{
kl for t ∈ [0, pτ)
0 for t ∈ [pτ, τ) , and kg(t) =
{
0 for t ∈ [0, pτ)
kg for t ∈ [pτ, τ)
. (4)
Thus, antibiotics are present during a fraction p of the period τ , and absent during the remaining fraction
1− p of the period.
Clearly, this is a simplification of reality because the concentration of an antibiotic is not expected to
be of the bang-bang type. In a more realistic model, the functions kd(t), kl(t) and kd(t) would be replaced
by functions depending on (at least) a new state variable for the concentration of the antibiotic, and the
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periodicity would arise through a periodic forcing term in the equation for this new variable. We leave the
study of such a model to the future.
Throughout the rest of this paper we assume that the net effect of the antibiotic alone is lethal to the
susceptible population:
1− kd − kl < 0. (5)
Note that this assumption is valid for the parameter values related to the experiments described in [5].
The main purpose of this paper is to investigate how the behavior of system (1) − (3) with (4) changes
qualitatively in terms of p.
3 Preliminary results
In this section we collect a couple of basic results concerning the dynamical behavior of (1) − (3) with (4).
For a real-valued function x(t), we denote the extended real numbers lim inft→∞ x(t) and lim supt→∞ x(t)
by x∞ and x∞ respectively.
Lemma 1. System (1)− (3) with (4) has R3+ as a forward invariant set, and it is dissipative.
Proof. The first assertion is obvious. Dissipativity follows by considering the dynamics of
M = Bs +Bp + Y S,
given by
M˙ = D(Y S0 −M)− kd(t)f(S)Bs ≤ D(Y S0 −M),
and hence
M∞ ≤ Y S0.
Not only are all state components of every solution ultimately bounded from above by some constant
which does not depend on initial conditions, we also notice in the following Lemma, that S(t) is ultimately
bounded from below by some positive constant which is independent of initial conditions.
Lemma 2. There is a constant θ > 0 such that for all solutions of (1) − (3) with (4), there holds that
S∞ ≥ θ.
Proof. Consider the function g(x) := f(x)S0−D(S0−x). Then g is increasing with g(0) < 0 and g(S0) > 0,
hence by the intermediate value theorem, there is a unique θ ∈ (0, S0) such that g(θ) = 0. We will show
that S∞ ≥ θ. If not, then since B∞s ≤ Y S0 by the proof of Lemma 1, it follows from Corollary 2.4 in [23]
-a consequence of the famous Fluctuation Lemma- applied to (2) that
0 ≥ lim inf
t→∞
[
D(S0 − S∞)− f(S∞)Bs(t)
Y
]
≥ D(S0 − S∞)− f(S∞)S0
> D(S0 − θ)− f(θ)S0,
which contradicts that g(θ) = 0.
4 Analysis of the extreme cases p = 0 and p = 1.
First we study the cases where antibiotic is either present or absent for all times. Our conclusions are the
expected ones: When antibiotic is present continuously, all susceptible cells are killed, and consequently
the persisters die out as well since they can only survive if susceptible cells become persisters. When the
population is never exposed to antibiotics, then all persisters revert to the susceptible state, and ultimately
the population will consist entirely of susceptible cells (provided the dilution rate is not too high).
Lemma 3. 1. Case p = 1 (continuous antibiotic dosing). The steady state (Bs, Bp, S) = (0, 0, S0)
of system (1)− (3) with (4) is globally asymptotically stable.
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2. Case p = 0 (never antibiotic dosing). If D < f(S0), then all solutions (Bs(t), Bp(t), S(t)) with
Bs(0) + Bp(0) > 0 converge to the steady state (Bs, Bp, S) = (B∗s , 0, S
∗), where S∗ ∈ (0, S0) is the
unique positive value satisfying f(S∗) = D, and B∗s = (S
0 − S∗)Y .
Proof. 1. If p = 1, then kd(t) ≡ kd, kl(t) ≡ kl and kg(t) ≡ 0 for all t. By (5) it follows that for all
solutions, B˙s ≤ −DBs, and hence Bs(t)→ 0 as t→∞. This suggests that we should study the linear
limiting system
B˙p = −DBp
S˙ = D(S0 − S)
whose solutions clearly converge to (Bp, S) = (0, S0). The conclusion now follows immediately by
applying Theorem F.1 in [20].
2. If p = 0, then kd(t) = kl(t) ≡ 0 and kg(t) = kg for all t. Then the restriction on the initial condition
implies that Bs(t) > 0 for all t > 0. Notice that Bp(t)→ 0 as t→∞, suggesting we should study the
limiting system
B˙s = [f(S)−D]Bs
S˙ = D(S0 − S)− f(S)Bs
Y
This is the classical chemostat model of a single cell population growing on a single nutrient, described
in [20]: all solutions with Bs(0) > 0 converge to (Bs, S) = (B∗s , S
∗) under the assumptions of the
Lemma. The conclusion follows again by Theorem F.1 in [20].
5 The case of periodic dosing: p ∈ (0, 1).
In this section we deal with the τ -periodic model (1)− (3) with (4), assuming that p ∈ (0, 1). We will also
assume that the dilution rate is not too large, as in Lemma 3:
D < f(S0). (6)
Notice that system (1)− (3) with (4) has a steady state E0 := (Bs, Bp, S) = (0, 0, S0), regardless of the
value of p. To determine its stability properties, we determine the τ -periodic variational equation at E0:
z˙ =
(1− kd(t)− kl(t))f(S0)−D kg(t) 0f(S0)kl(t) −(kg(t) +D) 0
− f(S0)Y 0 −D
 z
and the Floquet multipliers of this system are e−Dτ (which is of course inside the unit circle of the complex
plane) and the Floquet multipliers of
x˙ =
(
(1− kd(t)− kl(t))f(S0)−D kg(t)
f(S0)kl(t) −(kg(t) +D)
)
x
Using (4), these Floquet multipliers are the eigenvalues of the following matrix:
Φ := e(1−p)τA2 epτA1 , (7)
where
A1 :=
(
(1− kd − kl)f(S0)−D 0
klf(S0) −D
)
, and A2 :=
(
f(S0)−D kg
0 −(kg +D)
)
(8)
are triangular, quasimonotone matrices. Notice also that A1 is Hurwitz by (5), and that A2 has one negative
and one positive eigenvalue by (6).
Since A1 and A2 are quasi-monotone (i.e. their off-diagonal entries are all non-negative), it follows that
their matrix exponentials are (entry-wise) non-negative, triangular matrices and then their product Φ is a
(entry-wise) positive matrix whose spectral radius ρ(Φ) is an eigenvalue by the Perron-Frobenius Theorem[3].
Consequently, to determine stability of E0, we need to establish whether or not ρ(Φ) is inside the unit circle:
If ρ(Φ) < 1, then E0 is locally asymptotically stable. If ρ(Φ) > 1, then E0 is unstable. Summarizing, we
have established
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Theorem 1. Let p ∈ (0, 1), and assume that (6) holds. Then the steady state E0 = (0, 0, S0) is locally stable
for (1)− (3) with (4) if ρ(Φ) < 1, but unstable if ρ(Φ) > 1.
Our main concern is knowing how ρ(Φ) varies as a continuous function of p (this variation is continuous
since eigenvalues of a matrix are continuous functions of its entries, and clearly the entries of Φ are continuous
in p). For p = 0 (never using antibiotic), and hence also for p near 0 by continuity of ρ(Φ), we have that
ρ(Φ) = ρ(eτA2) = e(f(S
0)−D)τ > 1. This is in accordance with Lemma 3, where it was shown that all
solutions with Bs(0) + Bp(0) > 0 converge to (B∗s , 0, S
∗), and thus E0 = (0, 0, S0) must be unstable. For
p = 1 (using antibiotic continuously), and hence also for p near 1, we have that ρ(Φ) = ρ(eτA1) = e−Dτ < 1.
This is in accordance with Lemma 3 as well because it was shown there that all solutions converge to E0 in
this case.
We can actually determine the dependence of ρ(Φ) on p explicitely because fortunately, both A1 and
A2 are diagonalizable (their eigenvalues are distinct), which simplifies the computation of their matrix
exponentials somewhat. It is easily verified that
A1 = T1D1T−11 and A2 = T2D2T
−1
2 ,
where
T1 =
(
1− kd − kl 0
kl 1
)
, D1 =
(
(1− kd − kl)f(S0)−D 0
0 −D
)
and
T2 =
(
1 kg
0 −(f(S0) + kg)
)
, D2 =
(
f(S0)−D 0
0 −(kg +D)
)
,
and thus using (7) that
Φ = T2 e(1−p)τD2 T−12 T1 e
pτD1 T−11 .
A lengthy algebraic calculation shows that the positive matrix Φ =
(
Φ11 Φ12
Φ21 Φ22
)
is given by
cΦ11 = −(1− kd − kl)(f(S0) + kg) eτ [f(S0)−D−p(kd+kl)f(S0)]
+kgkl
(
e(1−p)τ(f(S
0)−D)− e−(1−p)τ(kg+D)
)(
e−pτD − epτ [(1−kd−kl)f(S0)−D]
)
,
cΦ12 = −kg(1− kd − kl) e−pτD
(
e(1−p)τ(f(S
0)−D)− e−(1−p)τ(kg+D)
)
,
cΦ21 = kl(f(S0) + kg) e−(1−p)τ(kg+D)
(
e−pτD − epτ [(1−kd−kl)f(S0)−D]
)
and
cΦ22 = −(f(S0) + kg)(1− kd − kl) e−τ((1−p)kg+D)
where
c = −(1− kd − kl)(f(S0) + kg)
is a positive constant, independent of p.
Since Φ is a positive matrix, its spectral radius can now be calculated explicitly in terms of its entries:
ρ(Φ) =
Φ11 + Φ22 +
√
(Φ11 − Φ22)2 + 4Φ12Φ21
2
. (9)
6 Conditions for treatment failure
In this section we show that the spectral radius ρ(Φ) also plays a key role in the global behavior of system
(1)−(3) with (4) and p ∈ (0, 1). We will show that if ρ(Φ) > 1, then not only is E0 unstable as we have shown
in Theorem 1, but treatment fails globally, because both cell populations persist uniformly. In addition we
will show that there are positive periodic solutions.
Theorem 2. Let p ∈ (0, 1), and assume that (6) holds. If ρ(Φ) > 1, then treatment fails and the population
is uniformly persistent, i.e. there is some ∗ > 0 (independent of initial conditions), such that all solutions
of (1)− (3) with (4) and Bs(0) > 0, have the property that:
Bs(t) > ∗, and Bp(t) > ∗, for all sufficiently large t.
Moreover, there are τ -periodic solutions (Bs(t), Bp(t), S(t)) with Bs(t), Bp(t) > 0 for all t.
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Proof. Define the following matrix:
Φ˜() = e(1−p)τA˜2() epτA˜1(),
where
A˜1() :=
(
f(S0 − )− (kd + kl)f(S0 + )−D 0
klf(S0 − ) −D
)
, and A˜2() :=
(
f(S0 − )−D kg
0 −(kg +D)
)
Notice that Φ˜(0) = Φ, and thus since ρ(Φ) > 1, it follows that
ρ(Φ˜()) > 1, for all sufficiently small  > 0, (10)
as well, because the spectral radius of any matrix is continuous with respect to its entries. We fix some  > 0
such that (10) holds.
We will first show that Bs is uniformly weakly persistent, i.e. that there is some ′ > 0 such that if
Bs(0) > 0, then B∞s ≥ ′. By contradiction, if Bs is not uniformly weakly persistent, then there is some
solution (Bs(t), Bp(t), S(t)) with Bs(0) > 0 such that
B∞s ≤
Y D
2f(S0)
. (11)
By Corollary 2.4 in [23] applied to (3), and since S∞ ≤ S0 by (3), we have that
0 ≥ lim inf
t→∞
[
D(S0 − S∞)− f(S∞)Bs(t)
Y
]
≥ D(S0 − S∞)− f(S
0)B∞s
Y
,
and hence by (11) that
S∞ ≥ S0 − 2 .
Thus, for some T ∗ > 0, there holds that S0−  ≤ S(t) ≤ S0 +  for all t ≥ T ∗. It follows from (1)− (2), that
for all t ≥ T ∗: (
B˙s
B˙p
)
≥
(
f(S0 − )− (kd(t) + kl(t))f(S0 + )−D kg(t)
kl(t)f(S0 − ) −(kg(t) +D)
)(
Bs
Bp
)
(12)
where the vector inequalities should be interpreted componentwise. Notice that the vector field on the
right-hand side of (12) is that of a τ -periodic, cooperative linear system whose principal fundamental matrix
solution evaluated over one period τ equals Φ˜(). By Kamke’s comparison Theorem (see e.g. Theorem B.1 in
Appendix B of [20]) it follows that for all t ≥ T ∗, the vector (Bs(t), Bp(t))T is not smaller (component-wise)
than the solution starting in (Bs(T ∗), Bp(T ∗))T of the τ -periodic, cooperative linear system with vector field
given in the right-hand side of (12). But all non-zero, non-negative solutions of the linear system diverge
because ρ(Φ˜()) > 1. Then so does (Bs(t), Bp(t)), and this contradicts (11). We have thus shown that Bs is
uniformly weakly persistent.
Next we establish that Bs is in fact uniformly strongly persistent. This follows from Theorem 1.3.3
in [24], applied to the map P which maps (Bs(0), Bp(0), S(0))T ∈ X to (Bs(τ), Bp(τ), S(τ))T , where X :=
{(Bs, Bp, S)T ∈ R3+ | Bs+Bp+Y S ≤ Y S0 }, X0 := {(Bs, Bp, S)T ∈ X | Bs 6= 0} and ∂X0 := {(Bs, Bp, S)T ∈
X | Bs = 0}. The map P is continuous and maps X0 into itself, and it has a global attractor because it is
compact and dissipative. It follows that there is some ∗1 > 0, independent of initial conditions, such that if
Bs(0) > 0, then lim infn→∞Bs(nτ) > ∗1, and also that lim inft→∞Bs(t) > 
∗
1 by Theorem 3.1.1 in [24].
Next we show that uniform strong persistence of Bs, implies uniform strong persistence of Bp. Consider
equation (2) and notice that for all sufficiently large t:
B˙p ≥ kl(t)f(θ)Bs − (kg(t) +D)Bp ≥ kl(t)f(θ)
∗
1
2
− (kg(t) +D)Bp,
where θ is the positive constant from Lemma 2. It is not hard to show that the linear equation
z˙ = kl(t)f(θ)
∗1
2
− (kg(t) +D)z,
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has a positive τ -periodic solution p(t) and that all non-negative solutions converge to it. Therefore, it follows
that for all sufficiently large t,
Bp(t) ≥ p∞2 ,
establishing uniform strong persistence for Bp, since p∞ is independent of initial conditions. We conclude
the proof of uniform strong persistence of Bs and Bp by setting ∗ = min{∗1, p∞2 }.
Finally, to show that there are τ -periodic solutions with Bs(t), Bp(t) > 0, we apply Theorem 1.3.6 from
[24] applied to the continuous map P defined above. We have already remarked that this map is continuous,
maps X0 into itself, is dissipative and compact, and we have just proved that it is uniformly strongly
persistent with respect to (X0, ∂X0). Observe also that X0 is relatively open in X, and that X0 is convex.
Then by Theorem 1.3.6 from [24], the map P has a fixed point in X0, and this in turn implies the existence
of τ -periodic solutions with Bs(t) > 0 for (1)− (3). The same argument as the one used above to establish
uniform strong persistence of Bp(t), shows that these τ -periodic solutions are such that Bp(t) > 0 as well.
7 Numerical example
We use the following numerical values: The per capita growth rate is of Michaelis-Menten type:
f(S) =
µS
ks + S
, where µ = 0.417 hs−1 and ks = 0.2 mgl−1,
and the parameters
kd = 3, kl = 0.1, kg = 0.5 h−1, and τ = 10 h.
The chemostat setting requires that we specify two additional parameters:
D = 0.1 h−1 and S0 = 1 mgl−1.
It can be easily verified that these choices satisfy the conditions (5) and (6). Note that there is no need to
specify the yield coefficient Y in order to calculate ρ(Φ). Indeed, the matrix Φ in (7) does not depend on Y .
The graph of the spectral radius ρ(Φ) in terms of p, determined using formula (9), is given in Figure 1.
We see that ρ(Φ) = 1 when p is approximately equal to 0.242. Clearly, ρ(Φ) is not monotone, and it has
a global mimimum of approximately 0.098 which is achieved at p ≈ 0.612 (determined numerically using
Mathematica). Thus, the optimal strategy in a dosing experiment with a period of τ = 10 hours occurs for a
dosing duration of pτ ≈ 6.12 hours. Here, optimality means that eradication happens as quickly as possible.
Let us also illustrate what happens if p equals approximately 0.205. Then ρ(Φ) equals approximately
1.436, implying that treatment fails. It appears that the solution of (1) − (3) with Y = 1 (and all other
parameters as above) starting from the initial condition (Bs, Bp, S) = (0.3, 0, 0.4) converges to a τ -periodic
solution, see Figures 2 and 3. These observations are in accordance with Theorem 2.
We also see that if p = 13 , then ρ(Φ) equals approximately 0.426. Then it follows from Theorem 1 that
E0 is locally stable. Figures 4 and 5 illustrate this by indicating that for the solution with the same initial
condition (Bs, Bp, S) = (0.3, 0, 0.4) as above, treatment is successful.
Finally we remark that the spectral radius of Φ may be monotone: If we change the value of kd from 3 to
1, and leave all other parameters unchanged, then ρ(Φ) is a decreasing function of p ∈ [0, 1], and achieves its
minimum at p = 1. This indicates that for this case, the optimal strategy is to use antibiotics continuously,
see Figure 6.
8 Discussion
Bacterial infections are a source of problems in a wide variety of situations including industrial, environmental
and clinical settings. Growing understanding of the inability of antibiotics and biocides to treat these
infections has driven investigations into the cause of the failure of treatments. It is becoming increasingly
evident that persister cells must play an important role in protecting populations of bacteria. It has been
observed that other protective mechanisms including physiological and physical processes are not sufficient to
explain the observed failures [7, 4]. Moreover, because it is very difficult to investigate and classify persister
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Figure 1: Spectral radius of Φ for p ∈ [0, 1] (kd = 3, other parameters in text.)
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Figure 2: Times series for Bs and Bp. (p ≈ 0.205, ρ(Φ) ≈ 1.436 so treatment fails)
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Figure 3: Times series for S and Bs +Bp. (p ≈ 0.205, ρ(Φ) ≈ 1.436 so treatment fails)
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Figure 4: Times series for Bs and Bp. (p = 13 , ρ(Φ) ≈ 0.426, so treatment succeeds)
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Figure 5: Times series for S and Bs +Bp. (p = 13 , ρ(Φ) ≈ 0.426, so treatment succeeds)
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Figure 6: Spectral radius of Φ for p ∈ [0, 1] (kd = 1, other parameters in text).
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cells experimentally, mathematical modeling can play an important role in supporting hypotheses as well as
generating useful predictions.
We have described and analyzed a general model for the dynamics of persister formation in response to
antibiotic challenge. We have been able to provide a condition for the success/failure of antibiotic challenge
in a chemostat. We have found that there is an optimal strategy, that is one that kills the bacteria the
fastest. These results indicate that periodic dosing is an effective treatment protocol for a variety of bacteria,
substantially strengthening the results in [5]. The theoretical results were also confirmed by direct numerical
simulations.
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